These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10097034)

  • 21. Glucagon-related peptide 1 (GLP-1): hormone and neurotransmitter.
    Larsen PJ; Holst JJ
    Regul Pept; 2005 Jun; 128(2):97-107. PubMed ID: 15780429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GLP-1 and extra-islet effects.
    Ahrén B
    Horm Metab Res; 2004; 36(11-12):842-5. PubMed ID: 15655717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of glucagon-like peptide 1 on the hepatic glucose metabolism.
    D'Alessio D; Vahl T; Prigeon R
    Horm Metab Res; 2004; 36(11-12):837-41. PubMed ID: 15655716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Learning from the gut.
    Mattson MP; Perry T; Greig NH
    Nat Med; 2003 Sep; 9(9):1113-5. PubMed ID: 12949521
    [No Abstract]   [Full Text] [Related]  

  • 25. The incretins--outdated terminology in man?
    Edwards CM; Bloom SR
    Diabetologia; 1999 Sep; 42(9):1148-9. PubMed ID: 10447529
    [No Abstract]   [Full Text] [Related]  

  • 26. An interaction between hypothalamic glucagon-like peptide-1 and macronutrient composition determines food intake in rats.
    Choi YH; Anderson GH
    J Nutr; 2001 Jun; 131(6):1819-25. PubMed ID: 11385073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systems and interactions: an approach to the pharmacology of eating and hunger.
    Blundell JE
    Res Publ Assoc Res Nerv Ment Dis; 1984; 62():39-65. PubMed ID: 6695116
    [No Abstract]   [Full Text] [Related]  

  • 28. Intracerebroventricular injection of fusaric acid attenuates the anorexia by glucagon-like peptide-1 in the neonatal chick.
    Bungo T; Kawakami SI; Ohgushi A; Sashihara K; Saito N; Sugahara K; Hasegawa S; Denbow DM; Furuse M
    Pharmacol Biochem Behav; 2001; 70(2-3):251-5. PubMed ID: 11701195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro insulinomimetic [corrected] effects of GLP-1 in liver, muscle and fat.
    Valverde I; Villanueva-Peñacarrillo ML
    Acta Physiol Scand; 1996 Jul; 157(3):359-60. PubMed ID: 8830894
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of rat glicentin on intestinal adaptation in small intestine-resected rats.
    Hirotani Y; Taki M; Kataoka K; Kurokawa N; Satoh T; Sasaki K; Yanaihara C; Luo WQ; Yanaihara N
    Ann N Y Acad Sci; 1998 Dec; 865():601-5. PubMed ID: 9928077
    [No Abstract]   [Full Text] [Related]  

  • 31. Glucagon, glucagon-like peptide-1 and their receptors: an introduction.
    Holst JJ
    Acta Physiol Scand; 1996 Jul; 157(3):309-15. PubMed ID: 8830884
    [No Abstract]   [Full Text] [Related]  

  • 32. Gut hormones as pharmaceuticals. From enteroglucagon to GLP-1 and GLP-2.
    Holst JJ
    Regul Pept; 2000 Sep; 93(1-3):45-51. PubMed ID: 11033052
    [No Abstract]   [Full Text] [Related]  

  • 33. Sympathetic pathways mediate GLP-1 actions in the gastrointestinal tract of the rat.
    Giralt M; Vergara P
    Regul Pept; 1998 Apr; 74(1):19-25. PubMed ID: 9657354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The signal transduction of the glucagon-like peptide 1 receptor: fishing beyond the protein kinase level.
    Göke B; Steffen H; Göke R
    Acta Physiol Scand; 1996 Jul; 157(3):321-8. PubMed ID: 8830886
    [No Abstract]   [Full Text] [Related]  

  • 35. Targeted gene disruption in endocrine research--the case of glucagon-like peptide-1 and neuroendocrine function.
    Seeley RJ; Woods SC; D'Alessio D
    Endocrinology; 2000 Feb; 141(2):473-5. PubMed ID: 10650925
    [No Abstract]   [Full Text] [Related]  

  • 36. Anti-hypertensive and natriuretic effect of glucagon-like peptide 1 in Dahl S rats: a novel function for a pleotrophic hormone?
    Vollenweider P
    J Hypertens; 2003 Jun; 21(6):1079-80. PubMed ID: 12777941
    [No Abstract]   [Full Text] [Related]  

  • 37. Dietary interventions in noninsulin-dependent diabetes mellitus: new approaches.
    Woods SC; Seeley RJ
    Nutrition; 1998 Jun; 14(6):527-8. PubMed ID: 9646296
    [No Abstract]   [Full Text] [Related]  

  • 38. [Glucagon 2004: homage to Roger Assan].
    Lefèbvre P
    Journ Annu Diabetol Hotel Dieu; 2004; ():105-10. PubMed ID: 15259309
    [No Abstract]   [Full Text] [Related]  

  • 39. Neuroregulators and feeding: implications for the pharmacological manipulation of hunger and appetite.
    Blundell JE
    Rev Pure Appl Pharmacol Sci; 1982; 3(4):381-462. PubMed ID: 6137866
    [No Abstract]   [Full Text] [Related]  

  • 40. The homeostatic dynamics of feeding behaviour identify novel mechanisms of anorectic agents.
    McGrath TM; Spreckley E; Rodriguez AF; Viscomi C; Alamshah A; Akalestou E; Murphy KG; Jones NS
    PLoS Biol; 2019 Dec; 17(12):e3000482. PubMed ID: 31805040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.